Livongo Health Inc

Livongo Health Inc

  • Price (USD)72.81
  • Today's Change-1.60 / -2.15%
  • Shares traded2.69m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 02 2020 21:00 BST.
More ▼

Profile data is unavailable for this security.

About the company

Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company’s Livongo platform offers a range of solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. The Company uses a digital approach to delivering evidence-based interventions including cognitive behavioral therapy, acceptance and commitment therapy, positive psychology, mindfulness, and motivational interviewing to help resolve clinical conditions, build resiliency, manage stress, improve mood, sleep better, or simply find daily inspiration.

  • Revenue in USD (TTM)206.96m
  • Net income in USD-45.94m
  • Incorporated2008
  • Employees671.00
  • Location
    Livongo Health Inc150 W Evelyn AveMOUNTAIN VIEW 94041-1555United StatesUSA
  • Phone+1 (312) 357-5450
  • Websitehttps://www2.livongo.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
NeoGenomics, Inc.419.28m3.45m3.74bn1.70k1,064.077.07108.058.930.03180.03183.984.790.662614.904.59246,637.100.5455-0.07380.6136-0.08346.7745.160.8233-0.11352.883.160.1694--47.7336.2531.5047.8839.64--
1life Healthcare Inc292.00m-79.74m4.83bn1.70k--10.07--16.55-0.6514-0.65142.393.80------171,767.10--------37.88---27.81--4.75--0.0047--29.89---18.32------
LHC Group, Inc.2.09bn98.89m5.60bn15.17k55.983.8540.762.683.173.1766.9145.990.9893--6.74137,806.705.596.266.677.5636.6137.095.654.90--14.420.16350.0014.9323.1850.5734.39-16.35--
Encompass Health Corp4.66bn342.40m6.18bn31.57k17.994.289.441.323.453.4546.9414.530.7956--8.93147,703.507.337.249.138.9996.2896.199.218.91--4.230.647433.987.6614.1723.3211.4916.557.12
Amedisys Inc1.98bn127.33m6.61bn21.30k53.029.7344.293.343.853.8559.8620.981.51--7.8492,956.719.788.5712.7811.6941.3741.166.484.28--19.490.36510.0017.6310.186.2757.73-8.06--
Livongo Health Inc206.96m-45.94m7.12bn671.00--14.13--34.41-0.5023-0.50232.255.150.55063.915.03336,520.30-12.21---13.67--73.85---22.17--10.23--0.00--148.71---65.05------
Chemed Corporation1.99bn231.15m7.42bn16.64k33.4110.8026.503.7213.9913.99120.5943.281.70198.2615.67119,723.5019.6915.6524.5419.6132.1930.6211.608.630.776149.810.189711.968.755.897.0017.234.008.10
Universal Health Services, Inc.11.40bn720.84m7.95bn67.70k11.421.476.470.6978.198.19129.7263.740.9771--7.38168,442.206.297.387.408.67----6.447.510.98926.380.40945.615.636.765.208.3210.1314.87
Davita Inc11.49bn816.13m9.87bn65.00k13.925.075.960.85945.826.3579.8615.990.571479.286.09176,717.005.154.477.675.8031.0129.499.017.131.774.890.71870.00-0.1436-2.3014.45-0.4923.63--
Data as of Jul 02 2020. Currency figures normalised to Livongo Health Inc's reporting currency: US Dollar USD

Institutional shareholders

13.48%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Mar 20202.46m2.51%
The Vanguard Group, Inc.as of 31 Mar 20202.00m2.05%
Franklin Advisers, Inc.as of 31 Mar 20201.72m1.76%
Columbia Wanger Asset Management LLCas of 31 Mar 20201.58m1.62%
Credit Suisse Securities (USA) LLC (Broker)as of 31 Mar 20201.00m1.02%
Jennison Associates LLCas of 31 Mar 2020950.33k0.97%
SSgA Funds Management, Inc.as of 31 Mar 2020927.89k0.95%
Gilder, Gagnon, Howe & Co. LLCas of 31 Mar 2020892.97k0.91%
BlackRock Advisors LLCas of 31 Mar 2020882.65k0.90%
Matrix Capital Management Co. LPas of 31 Mar 2020767.94k0.79%
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.